ProMIS Neurosciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

FAIR VALUE MEASUREMENTS (Tables)

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2023

FAIR VALUE MEASUREMENTS

Summary of major categories of assets and liabilities measured at fair value on a recurring basis


		As of December 31, 2023
		Level 1			Level 2				Level 3		Total
Assets:
Short-term investments		$	32,358		$	—		$	—		$	32,358
Total assets measured at fair value		$	32,358		$	—		$	—		$	32,358
Liabilities:
Share-based compensation liability		$	—		$	—		$	422,002		$	422,002
Warrant liability		$	—		$	—		$	94,185		$	94,185
Total liabilities measured at fair value		$	—		$	—		$	516,187		$	516,187


		As of December 31, 2022
		Level 1			Level 2				Level 3		Total
Assets:
Short-term investments		$	31,009		$	—		$	—		$	31,009
Total assets measured at fair value		$	31,009		$	—		$	—		$	31,009
Liabilities:
Share-based compensation liability		$	—		$	—		$	—		$	—
Warrant liability		$	—		$	—		$	1,859,374		$	1,859,374
Total liabilities measured at fair value		$	—		$	—		$	1,859,374		$	1,859,374